Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Dáil Éireann díospóireacht -
Thursday, 21 Nov 2002

Vol. 557 No. 6

Written Answers. - Cancer Treatment Services.

John Gormley

Ceist:

186 Mr. Gormley asked the Minister for Health and Children if his attention has been drawn to a memo from the chief executive officer of the Mater Hospital seeking to cap the range of cancer drugs available to patients; his views on whether this will limit public patients' access to certain expensive drugs; and if he will make a statement on the matter. [23172/02]

The Eastern Regional Health Authority has informed my Department that, as part of its normal work in line with the cancer strategy, it is reviewing cancer services, including staffing, facilities, activity protocols and safety standards. As part of its ongoing work, the ERHA liaises with oncologists across the region in conjunction with their respective hospitals on these issues. This work is not and was never about capping budgets for cancer treatments. Its objective is to ensure cancer patients in the eastern region have access to the most modern effective drug treatments.

Since the implementation of the national cancer strategy commenced in 1997, more than €103 million has been invested to date in the development of appropriate treatment and care services for people with cancer. Cancer services throughout the country have benefited from this investment which far exceeds the £25 million requirement which was initially envisaged under the national cancer strategy. Among a range of other initiatives, this investment has enabled the funding of 80 additional consultant posts in key areas such as medical oncology, radiology, symptomatic breast disease, palliative care, histopathology and haematology, together with support staff. Since November 2001, this Government has invested €3.5 million in the development of cancer clinical trials, ensuring cancer patients in Ireland have access to the most modern and effective drug therapies.

As the Deputy may be aware, an additional sum of €29 million is being allocated in 2003 for cancer services. This investment will ensure that next year we continue to address increasing demands in cancer services, including oncology drug treatments. In recognition of the need to further develop cancer services, the national health strategy has identified the need for the preparation of a new national cancer strategy. The national cancer strategy, 2003, is being developed by the National Cancer Forum in conjunction with the Department of Health and Children and will set out the key investment areas to be targeted for the development of cancer services over the next seven years. As part of this work, the National Cancer Forum has established a number of multidisciplinary subgroups, including a subgroup on evidence based medicine. This group is currently preparing a framework for the development, implementation, monitoring and updating of guidelines for the treatment of patients with cancer. The recommendations of these subgroups will inform the development of the new national cancer strategy, 2003.
Barr
Roinn